SCHEMBL6404489

SCHEMBL6404489

CC(C)N(C=O)c1ccc(Cl)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.41
HSD17B10 Q99714 2/20 0.41
KDM4E B2RXH2 1/20 0.41
HPGD P15428 1/20 0.41
ALOX15 P16050 1/20 0.41
CHRNB2 P17787 1/20 0.37
CHRNB4 P30926 1/20 0.37
CHRNA3 P32297 1/20 0.37
CHRNA4 P43681 1/20 0.37
CES1 P23141 2/20 0.37
RORC P51449 1/20 0.36
ADRB2 P07550 1/20 0.35
TDP1 Q9NUW8 2/20 0.35
TAAR1 Q96RJ0 2/20 0.35
LIPE Q05469 1/20 0.35
USP2 O75604 1/20 0.35
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA3 P07451 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL149788 0.78 ALDH1A1 (0.40) ALDH1A1ALOX15CHRNB2CHRNB4CHRNA3
SCHEMBL1855148 0.77 CHRNB2 (0.43) ALDH1A1KDM4ECHRNB2CHRNB4CHRNA3
SCHEMBL11201182 0.77 FFAR2 (0.38) ALDH1A1HSD17B10ALOX15CHRNB2CHRNB4
SCHEMBL9672759 0.75 CES2 (0.35) ALDH1A1CES1CES2
SCHEMBL2096460 0.71 ALDH1A1 (0.45) ALDH1A1HSD17B10KDM4EHPGDALOX15
SCHEMBL16021810 0.70 ADRB2 (0.48) ALDH1A1HSD17B10KDM4EHPGDALOX15
SCHEMBL3096128 0.70 HSD17B10 (0.46) ALDH1A1HSD17B10KDM4EHPGDALOX15
SCHEMBL28535945 0.70 ALDH1A1 (0.43) ALDH1A1HSD17B10KDM4EHPGDALOX15
SCHEMBL19809851 0.70 KMT2A (0.35) ALDH1A1HSD17B10ALOX15CHRNB2CHRNB4
SCHEMBL8038732 0.69 HSD17B10 (0.44) ALDH1A1HSD17B10KDM4EHPGDALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050187390-A1 Bicyclic heteroaryl derivatives GENELABS TECHNOLOGIES, INC. 2005-08-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050187390-A1 Bicyclic heteroaryl derivatives HAVCR2, MAVS, ZC3HAV1 ALDH1A1 2299/4885HSD17B10 868/4885KDM4E 2491/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.